Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2171754 | Cytotherapy | 2014 | 11 Pages |
Abstract
These results suggest that ASC-PEDF CCM can promote reprogramming of tumor cells in a paracrine manner. An improved understanding of genetic and epigenetic events in prostate cancer growth in response to PEDF paracrine therapy would enable a more effective use of ASC-PEDF, with the goal of achieving safer yet more potent anti-tumor effects.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Olga Zolochevska, Joseph Shearer, Jayne Ellis, Valentina Fokina, Forum Shah, Jeffrey M. Gimble, Marxa L. Figueiredo,